Clinical Trials
51
Active:0
Completed:25
Trial Phases
4 Phases
Phase 1:1
Phase 2:2
Phase 4:7
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (48 trials with phase data)• Click on a phase to view related trials
Not Applicable
38 (79.2%)Phase 4
7 (14.6%)Phase 2
2 (4.2%)Phase 1
1 (2.1%)GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial
Phase 4
Completed
- Conditions
- Ventilator Associated Pneumonia
- Interventions
- Drug: Guidelines-based antibiotics choice
- First Posted Date
- 2018-04-23
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Osaka General Medical Center
- Target Recruit Count
- 206
- Registration Number
- NCT03506113
- Locations
- 🇯🇵
Chukyo Hospital, Nagoya, Aichi, Japan
🇯🇵Sapporo City General Hospital, Sapporo, Hokkaido, Japan
🇯🇵Tajima Emergency and Critical Care Medical Center, Toyooka, Hyogo, Japan
Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
- First Posted Date
- 2008-07-15
- Last Posted Date
- 2008-07-15
- Lead Sponsor
- Osaka General Medical Center
- Registration Number
- NCT00716001
Right Ventricular Septal Pacing for the Prevention of Left Ventricular Dysfunction in Patients With Atrio-Ventricular Block
Phase 4
- Conditions
- Atrio-Ventricular Block
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2008-07-03
- Lead Sponsor
- Osaka General Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT00709774
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection
Phase 4
Completed
- Conditions
- Emergent Coronary Procedure
- Interventions
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2010-07-20
- Lead Sponsor
- Osaka General Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT00700375
- Locations
- 🇯🇵
Osaka General Medical Center, Osaka, Japan
N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure
Phase 4
- Conditions
- Acute Heart FailureAcute Myocardial Infarction
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2008-06-19
- Lead Sponsor
- Osaka General Medical Center
- Target Recruit Count
- 160
- Registration Number
- NCT00692718
News
No news found